Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PALIPERIDONE USP, with a corresponding US DMF Number 27503.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 12, 2014, and payment made on September 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II